Navigation Links
Ben Venue Laboratories, Inc. Named Recipient of the Governor's Award for Outstanding Achievement in Environmental Stewardship
Date:12/8/2008

BEDFORD, Ohio, Dec. 8 /PRNewswire/ -- Ben Venue Laboratories, Inc. is pleased to be the recipient of the 2008 Governor's Award for Outstanding Achievement in Environmental Stewardship presented by Governor Ted Strickland and the State of Ohio Environmental Protection Agency on December 3, 2008. The award recognizes Ben Venue for its environmental, health and safety management system that strives to promote a safe and healthy manufacturing environment, including brownfield reuse and re-development, LEED (Leadership in Energy and Environmental Design) construction design and application for Silver Certification for its recently completed 90,000 square foot Lab and Office facility, recycling and reuse, energy saving, and water conservation.

Coordinated by the Ohio EPA, the award seeks to acknowledge Ohio businesses and organizations demonstrating a commitment to go above and beyond compliance, maintain aggressive environmental performance goals, and provide a process for communicating with others about program activities and progress toward established goals. Submitted nominations were rated and the Ohio EPA completed site audits with the finalists to select the eight chosen honorees. "I'm honored to recognize these forward-thinking award winners, which have all demonstrated cutting-edge achievements and a commitment to environmental stewardship in Ohio," said Ohio EPA Director Chris Korleski in a press release issued by the Governor's office. Governor Ted Strickland added, "These companies are leaders in protecting Ohio's natural resources while implementing innovative approaches that reduced the cost of doing business, improved company efficiency, and enhanced the quality of life and the environment in their communities. I commend their efforts," More information about the award is available at: http://www.epa.state.oh.us/ocapp/stewardship.html.

Ben Venue Laboratories, Inc. Cares

Caring for the environment is one of the many ways Ben Venue works to make a difference. Each day, employees work to fulfill the company mission to provide their customers with pharmaceutical products that improve people's health and quality of life. This commitment to others also stems deeply into how the organization gives back to the community through many avenues including responsible environmental stewardship. With support from all levels of the organization, the environmental health and safety management system continues to take on new life with each passing year. From activities including the careful consideration for environmentally-friendly construction design to numerous grass-roots employee efforts, Ben Venue cares about the footprint it maintains and the impact on the environment. Employees started a Waste Minimization and Recycling Team in 2005 to identify routes to recycle waste streams. Successes include saving valuable landfill space and significantly reducing waste disposal costs. The company recycled and reused 35 tons of material in 2005, 360 tons in 2006 and over 730 tons in 2007. A precious-metal recycling program that began in 2007 recovered over 170 troy ounces of platinum for a return of more than $265,000. A water reclamation system installed in 2006 saved more than 7 million gallons of water in 2006 with a cost savings of $57,000. The most recent accomplishment was the completion of the LEED Silver Certification application for its newest facility, a 90,000 square foot Lab and Office building. President and COO, Thomas Murphy stated, "This commitment is at the heart of how we conduct business today and is sure to bring about even greater results for the future."

About Ben Venue Laboratories, Inc.

Ben Venue Laboratories, Inc. was founded in 1938 and is a leading contract manufacturer of highly complex, sterile injectable drug products for the global pharmaceutical industry. It also markets its own line of generic sterile injectables to hospitals and alternate care markets in North America through its Bedford Laboratories division -- currently offering a variety of products including oncology, cardiovascular, anesthesia, antipsychotic and various other products. BVL has been under contract with the National Cancer Institute since 1967 to develop parenteral dosage forms for many anticancer agents. It has also manufactured various AIDS-specific drugs in conjunction with the NCI. Ben Venue is located in Bedford, Ohio and employs more than 1,100 people. For more information on Ben Venue Laboratories, visit www.benvenue.com.

Ben Venue is a U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

About Boehringer Ingelheim

Boehringer Ingelheim Corporation based in Ridgefield, CT, is the US headquarters to seven subsidiaries and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 135 affiliates in 47 countries and approximately 39,800 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

In 2007, Boehringer Ingelheim posted net sales of US $15.0 billion (10.9 billion euro) while spending approximately one-fifth of net sales in its largest business segment, Prescription Medicines, on research and development.

For more information on Boehringer Ingelheim, please visit http://us.boehringer-ingelheim.com.


'/>"/>
SOURCE Ben Venue Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Hillenbrand, Inc. Reports Fourth-Quarter Revenue of $159 Million and Earnings Per Share of $0.31
2. Unilens Vision Reports Record First Quarter Revenue, Earnings and Royalty Income
3. PaperThin Experiences Record Growth : Grows Revenues, Expands Channel, and Maintains 95%+ Subscription Renewal Rate
4. Amilpar Revenues Grow 28% in the First 9 Months of 2008 and 4.5% Over Previous Quarter
5. AMN Survey: Nurses to Have Bigger Impact on Hospital Revenue
6. The Quantum Group Announces Continued Growth of Patient Base and Preliminary Revenue Guidance
7. Ocean Blue Plastic Surgery to Open This Month on Brickell Avenue
8. TransUnion Revenue Manager Addresses Red Flags Regulations
9. Medifast Diversified Business Model Drives Strong Revenue and Earnings Growth for the Third Quarter of 2008
10. Volcano Reports 40 Percent Growth in Quarterly Revenues
11. drugstore.com inc. Reports Solid Revenue Growth and Record Gross Margins in the Third Quarter of 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... Freed-Hardeman University President Joe ... signed a joint enrollment and degree completion agreement. The agreement, which begins ... degrees at FHU|Dickson. , The agreement allows students to be jointly admitted ...
(Date:2/5/2016)... ... February 05, 2016 , ... In the fourth ... country gathered at the La Valencia Hotel in San Diego, California to discuss ... named the year’s most outstanding franchise, walking away with the coveted David Wright ...
(Date:2/5/2016)... SARASOTA, Fla., (PRWEB) , ... February 05, 2016 , ... ... appetizing recipes just in time for this weekend’s Big Game. Take the stress out ... ingredients that will keep your guests happy at every stage of the game. , ...
(Date:2/5/2016)... ... February 05, 2016 , ... Stuart Bentkover, MD, FACS is ... to provide the most effective tattoo removal today, Dr. Bentkover is the only doctor ... by Cynosure, the PicoSure has been approved by the Food and Drug Administration (FDA) ...
(Date:2/5/2016)... ... February 05, 2016 , ... Health and wellness is a topic that should ... event they are experiencing an illness. Migraines are a severe form of a headache ... migraines would not wish the pain on their worst enemy, the feeling can last ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... Calif. , Feb. 4, 2016  Edwards Lifesciences ... patient-focused innovations for structural heart disease and critical care ... accelerated share repurchase (ASR) agreement with Morgan Stanley & ... stock.  This repurchase is part of the Company,s previously ... the Company,s common stock.  --> ...
(Date:2/4/2016)... Feb. 4, 2016 Worldwide Radiology Oncology ... growth as next generation systems provide a way ... for cancer surgery. New systems pinpoint the delivery ... has been such a problem previously, limiting the ... robots take cancer surgery far beyond what has ...
(Date:2/4/2016)... Calif. , Feb. 4, 2016  SciClone ... today announced it has entered into a settlement ... Commission (SEC) fully resolving the SEC,s investigation into ... (FCPA).  Under the terms of the settlement agreement, ... $12.8 million, including disgorgement, pre-judgment interest and a ...
Breaking Medicine Technology: